FLIC
South China Morning Post
Head of Hong Kong’s new drug regulator pledges to build trust, push innovation
The head of Hong Kong’s new drug regulatory body has pledged to build a fully capable and globally trusted agency that will become a catalyst for medical innovation rather than merely acting as a “miniature version” of existing overseas models. Dr Li Zili, controller of the Hong Kong Centre for Medical Products Regulation (CMPR), said that while many other places in Asia, such as mainland China, Singapore and Japan, had established regulatory agencies long ago, Hong Kong had a distinctive...
1 vote cast by the community
FLIC Trust Score70 / 100
How FLIC Trust Scores workFLIC Trust Scores turn community ratings into a 0–100 signal about how readers assess a story. Fake News votes lower the score, while Liberal, Conservative, and Independent classifications support it. The formula also rewards a balanced split between Liberal and Conservative ratings instead of treating one political viewpoint as automatically more trustworthy. Scores can change as more people vote and represent community judgment, not a factual verdict or substitute for reading the original reporting. Learn more about how FLIC works.
Open in FLIC App
or
Continue on Web